There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for SOPHiA GENETICS SA (SOPH) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.01, or -0.21%, to $4.85. The SOPHiA GENETICS SA has recorded 102 volume in the after hours trading session. Earlier, Yahoo Finance discussed this stock as it revealed SOPHiA GENETICS and Agilent Partner on Comprehensive Solution for Cancer Analysis.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
This NASDAQ-listed company operates within the Health Information Services industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $4.86 and fluctuated between $5.1000 as its day high and $4.4300 as its day low. The current market capitalization of SOPHiA GENETICS SA is $299.47M. A total of 0.52 million shares were traded on the day, compared to an average of 111.24K shares.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for SOPH in the last 3 months, the mean price target is $7.81 with high estimates of $12.00 and low estimates of $2.25. In terms of 52-week highs and lows, SOPH has a high of $9.31 and a low of $1.68.
As of this writing, SOPH has an earnings estimate of -$0.36 per share for the current quarter. EPS was calculated based on a consensus of 5 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.43.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 4 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SOPH is Buy with a score of 4.75. A total of 3 analysts rated the stock as Buy while 0 rated it as Overweight while 1 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.